Inflammatory Bowel Disease · Article 40

What Should Be Done When GERD Symptoms Persist Despite a Proton Pump Inhibitor?

Refractory GERD symptoms requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Refractory GERD symptoms clinical reference — Related free clinical resource: Endoscopy and Diagnostic Imaging.

Refractory GERD symptoms: practical clinical approach

This page focuses on Refractory GERD symptoms with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Refractory GERD symptoms

Clinical takeaway: For Refractory GERD symptoms, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer in brief: Persistent symptoms on a PPI should not automatically trigger more acid suppression. First confirm adherence and correct pre-meal dosing, then reassess whether symptoms are truly reflux-mediated. Endoscopy, ambulatory reflux monitoring and manometry are selected according to whether GERD has been objectively established. Many “PPI failures” prove to be reflux hypersensitivity, functional heartburn, rumination, achalasia or another disorder rather than uncontrolled acid reflux.[1,2]

Optimize the PPI before declaring failure

For most conventional PPIs, dosing 30–60 minutes before a meal improves acid suppression. Confirm adherence, timing and whether symptoms are heartburn, regurgitation, chest pain, cough or throat symptoms. Twice-daily therapy should be purposeful rather than automatic.

Ask whether GERD was ever proven

A prior severe erosive esophagitis, long-segment Barrett’s esophagus or abnormal reflux study establishes GERD. In a patient with unproven GERD and persistent symptoms, reflux monitoring off PPI is often the key diagnostic step. In proven GERD with persistent symptoms, impedance-pH monitoring on therapy can evaluate ongoing reflux and symptom association.[1,2]

Endoscopy has a targeted role

Endoscopy is indicated for alarm symptoms and can identify erosive disease, Barrett’s, stricture, eosinophilic esophagitis and alternative pathology. A normal endoscopy does not exclude GERD and should not automatically lead to indefinite high-dose PPI.

Manometry answers a different question

High-resolution manometry evaluates motility disorders and is important before antireflux procedures. It can identify achalasia and other motor disorders that may mimic reflux. It does not directly diagnose GERD.

Common non-GERD explanations

Functional heartburn.
Reflux hypersensitivity.
Rumination or supragastric belching.
Eosinophilic esophagitis.
Achalasia or another motor disorder.
Gastroparesis or functional dyspepsia.
Cardiac or musculoskeletal chest pain.

Do not escalate to a procedure without objective evidence

Antireflux surgery or endoscopic therapy works best in carefully selected patients with objective reflux and compatible symptoms. A procedure is unlikely to help functional heartburn and may cause harm.

Questions trainees should be able to answer

How should a conventional PPI be timed?
When is reflux monitoring done off versus on PPI?
Why is manometry required before many antireflux procedures?

Frequently asked questions

Should a second PPI always be tried? One switch can be reasonable, but repeated empiric switches are less useful than establishing whether symptoms are reflux-mediated.

Can a normal endoscopy coexist with GERD? Yes. Nonerosive reflux disease is common.

What if reflux testing is normal? Consider functional heartburn, reflux hypersensitivity and alternative diagnoses rather than escalating acid suppression.

References

1. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117:27-56.

2. Gyawali CP, Carlson DA, Chen JW, et al. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. Am J Gastroenterol. 2020;115:1412-1428.

3. Thomson ABR. Guideline-Based Management in Gastroenterology. CAPstone Academic Publishers; 2015. ISBN 978-1515078623.

Educational use only. This article is intended for clinicians and trainees and does not replace patient-specific medical judgment or local guidance.

← Back to Clinical Questions